Cell type identification is essential for single-cell RNA sequencing (scRNA-seq) studies that are currently transforming the life sciences. CHETAH (CHaracterization of cEll Types Aided by Hierarchical clustering) is an accurate cell type identification algorithm that is rapid and selective, including the possibility of intermediate or unassigned categories. Evidence for assignment is based on a classification tree of previously available scRNA-seq reference data and includes a confidence score based on the variance in gene expression per cell type. For cell types represented in the reference data, CHETAH's accuracy is as good as existing methods. Its specificity is superior when cells of an unknown type are encountered, such as malignant cells in tumor samples which it pinpoints as intermediate or unassigned. Although designed for tumor samples in particular, the use of unassigned and intermediate types is also valuable in other exploratory studies. This is exemplified in pancreas datasets where CHETAH highlights cell populations not well represented in the reference dataset, including cells with profiles that lie on a continuum between that of acinar and ductal cell types. Having the possibility of unassigned and intermediate cell types is pivotal for preventing misclassification and can yield important biological information for previously unexplored tissues.
INTRODUCTION
Single-cell RNA-sequencing (scRNA-seq) is transforming our ability to study heterogeneous cell populations [1] [2] [3] [4] [5] [6] . While tools to help interpret scRNA-seq data are developing rapidly [7] [8] [9] [10] [11] [12] [13] [14] [15] , challenges in data analysis remain 16 , with cell type identification a prominent example. Accurate cell type identification is a prerequisite for any study of heterogeneous cell populations, both when the focus is on subsets of a particular cell type of interest or when investigating the population structure as a whole [17] [18] [19] [20] [21] . The introduction of single cell RNA sequencing has paved the way for rapidly discovering previously uncharacterized cell types [22] [23] [24] and this application too would greatly benefit from efficient identification of known cell types prior to focusing on new types.
Research into tumor composition presents an even more challenging setting, as the RNA expression profile of malignant cells is often different from any known cell type, as well as unique to the patient or even to the biopsy 25, 26 . Malignant cells can sometimes be identified in scRNA-seq data 27 but this is not always feasible or even possible, for instance with tumors that do not harbor easily identified copy number variations. In both cases, a first sign of the malignancy of cells in the sample is their imperviousness to classification, simply because their expression profiles do not resemble that of any known, healthy cell type.
Cell type identification in scRNA-seq studies is currently often done manually, starting by identifying transcriptionally similar cells using clustering. This is frequently followed by differential expression analysis of the resulting cell clusters combined with visual marker gene inspection 4, 25, 26, [28] [29] [30] .
Such manual cell type identification is time-consuming and often subjective due to the choice of clustering method and parameters for example, or to the lack of consensus regarding which marker gene to use for each cell type. Such analyses are becoming more complex given the fast-expanding catalogue of defined cell types 16 . Canonical cell surface markers are also not always suitable in scRNA-seq studies because the transcripts of these genes may not be measurable in the corresponding cell type owing to low expression or to degradation of the mRNA. This is aggravated by technical difficulties (drop-out) and, more generally, by the poor correlation between protein expression and mRNA abundances 23 .
Recently, a number of cell type identification algorithms have emerged to address these problems. Automated methods such as scmap 31 and SingleR 32 base their cell type call on comparisons with annotated reference data using automatically chosen genes that optimally discriminate between cell types. A good cell type identification method should be both sensitive and selective. That is, it should correctly identify as many cells as possible, while not classifying cells when based on insufficient evidence. If the cell being identified is of a type that is not represented in the reference, such misclassification can easily occur. This is a concern when studying malignant cells which are often too heterogeneous to include in the reference data. To avoid overclassification, methods such as scmap 31 therefore leave cells unclassified if they are too dissimilar to any reference data.
Both the complete lack of classification as well as overclassification is unsatisfactory. For example, if the evidence for a very specific cell type assignment such as effector CD8 T-cell is not strong enough, a more general, less specific assignment such as T-cell may still legitimately be made and might still be useful. The reason for such an intermediate cell type assignment could be that the correct T-cell subtype is not part of the reference dataset, or even that there is insufficient read-depth for the more specific call to be made. An even more more interesting case is that of cells that are biologically of an intermediate type such as differentiating cells or cells undergoing transdifferentiation.
Here we present CHETAH (CHaracterization of cEll Types Aided by Hierarchical clustering), an algorithm that explicitly allows the assigningment of cells to an intermediate or unassigned type. The unassigned and intermediate types are inferred using a tree that is constructed from the reference data and which guides the classification. CHETAH's classification is a stepwise process that traverses the tree and, depending on the available evidence, ends at one of the reference cell types or halts at the unassigned or one of the intermediate types. CHETAH is able to correctly classify published datasets and, in comparison to other methods it performs equally or better when considering cells whose type is represented in the reference data. For cells of an unknown type, CHETAH is more selective, yielding a classification that is as fine-grained as is justified by the available data. The benefit of calling unassigned and intermediate types is highlighted in several tumor datasets, showing CHETAH is consistently selective. This makes CHETAH a powerful tool for identifying cells that are not in the reference, such as malignant tumor cells, novel or intermediate cell types. The latter is shown in an analysis of published pancreas datasets, where a manifest expression gradient of cells with types varying between acinar and duct cell is described. CHETAH is implemented in R 33 and is available at github.com/jdekanter/CHETAH. It comes with an extensive Shiny 34 application that makes exploration of the cell type identification process and the gene expression differences that support the classification very intuitive. CHETAH has been created bearing tumor analyses in mind, but as is demonstrated, it also complements existing methods for exploring previously uncharacterized non-cancerous tissues and cell types. Figure 1 . First a hierarchical classification tree is constructed from the reference scRNA-seq data. This tree guides the classification in a way that resembles the use of a taxonomic key. At each step of the process the cell to be classified is correlated to the expression profiles of the reference data. Each correlation is compared to the distribution of correlations of the reference cells per cell type to assess whether there is enough evidence to allow this cell to take the next step. If not, further classification of the cell stops and it is marked as unassigned if the evidence runs out at the top of the tree, or as intermediate if this happens within the classification tree.
METHODS

An outline of the CHETAH algorithm is depicted in
Classification also stops when a cell reaches one of the leaves of the tree. (A) Reference profiles (RPs) are created for each cell type by averaging the expression profiles of all reference cells (RCs) per type. A classification tree is computed from these RPs using Spearman correlation and average linkage. The input cells are classified in a top-to-bottom, stepwise process traversing the tree. In each node, the input cells are assigned to the left or right branch, or to the node itself, depending on the input cell's profile and confidence scores (B) For each input cell j, a profile score expressing cell j's similarity to each candidate RP is calculated (shown for RP1). To this end the fold-changes in expression of all genes between the candidate RP (here: RP1) and the mean of all the RPs in the other branch (here RP3 and RP4) are calculated. The 200 genes with the highest absolute fold-change are selected and used to correlate each individual reference cell to RP1. This results in a distribution of expected correlations of cells of the current candidate cell type. Likewise, the distribution of correlations of the union of all cell types under the other branch (here RC3 and RC4) to RP1 is calculated. The profile score of input cell j is based on the cumulative probabilities of cell j's correlation within these two distributions. (C) Lastly, cell j is assigned to the branch containing the RP with the maximal profile score (here RP3+4) but only if the confidence score for this assignment is large enough. If not, the cell's type is unassigned (if it is the top node of the tree) or one of the intermediate types (if it is further down). The confidence score is based on all profile scores under the current node.
Reference data
In order to classify input cells CHETAH requires scRNA-seq reference data along with cell type labels for each reference cell. The reference data needs to be normalized to an identical total number of transcripts per cell and should be expressed in log-scale. Malignant cells are best left out of the reference because they are too ill-defined and patient-specific 35 . In all the reference datasets used here, such cells cluster by patient whereas non-malignant cells largely cluster by cell type. The reference must contain at least 10 cells per cell type to adequately represent its transcriptional program as well as its variance. The reference must contain at least 10 cells per type to adequately represent its transcriptional program as well as its variance. Between 10 and 100 is optimal. More than 100 cells per cell type is superfluous and increases the computational burden.
Unless stated otherwise, the reference dataset used here consists of a combination of datasets of colorectal 36 , breast 37 , melanoma 25 and head-neck tumors 26 . The data for all these studies was generated using the Smart-Seq2 platform. The cell types of the reference dataset were based on published manual classification of cell clusters using marker gene expression. The melanoma and head-neck studies discuss the T-cells in terms of their CD4+, CD8+ and T-reg subtypes but not all of these labels are available for all the cells in the online material of these publications. These reference cells were therefore classified manually using the same marker genes as used in the publications. Cells of a dataset being classified are of course excluded from the reference. When comparing CHETAH and SingleR 32 results, the latter was run with averaged single-cell data because SingleR uses bulk, rather than single-cell expression profiles as its reference.
Classification tree
The first step is to create a reference profile (RP) for each cell type in the set of reference cells by averaging, for each cell type, the logged gene expression over all cells of that type ( Figure 1A ). The RPs are subsequently clustered hierarchically using Spearman correlation and average linkage to obtain the classification tree.
Hierarchical classification
The classification of input cells proceeds in a stepwise fashion, from the root to the leaves of the classification tree. At each step, the branch is selected that contains the reference cell type most likely to be the correct one, but the classification stops if the confidence in this decision becomes too low (see confidence score below). As described under profile score, the choice of the most likely cell type and therefore which branch to choose, is based on the cell's similarities to each of the individual RPs under each branch. The similarity of a cell to a RP under consideration (called the candidate RP), in the branch under consideration (called the candidate branch), is always in relation to all the RPs under the (socalled) other branch. During the classification process, only the leaf node data (i.e. from all cells of a particular reference cell type) are used. Any details of the tree topology under either branch are ignored, i.e. no hypothetical expression profiles are inferred for the intermediate tree nodes. After calculating the cell's similarities to all RPs under both branches, the cell is assigned to the branch that contains the cell type to which it is most similar, provided the evidence is strong enough based on the confidence score.
Feature selection
The similarity of a cell to a reference profile is based on their Spearman correlation. This correlation is calculated using the subset of genes that best discriminates between the candidate RP in the candidate branch, and the average expression profile of the other branch as a whole. (The latter is calculated as the mean of all RPs under that branch). The selection of the best subset of genes, a process known as feature selection, is not critical and good results are achieved when simply using the 200 genes that have the largest absolute fold-change between the candidate RP and the average expression profile of the other branch. It is important to note that the feature set, i.e. the subset of genes used to calculate similarities, is generally different for each RP and for each node of the classification tree.
Similarities
The similarity of a cell to a RP in the candidate branch is of course reflected in their correlation, but the values of these correlations to the various RPs cannot be directly used for comparisons. The reason is that the subset of genes used for each correlation is generally different for each RP and for each node.
The similarity of an input cell j to candidate RP x is therefore cast in relative terms by using the cumulative probabilities of this correlation within two different distributions of correlations. The first one is the distribution of self-correlations, that is, the distribution of the correlations of the individual cells constituting the candidate RP to that candidate RP itself. These self-correlations represent the typical correlation values for a cell that is really of that type. The second distribution is that of the nonself-correlations. They are the correlations, again to the candidate RP, of all the individual reference cells under the other branch. They represent the correlation values that can be expected for cells that are not of any type under the candidate branch. By contrasting the two cumulative probabilities a profile score is obtained that robustly points the way through the classification tree.
Profile scores
The two cumulative probabilities just defined are used to define the profile score " ( ), representing cell j's similarity to candidate RP x, as follows:
the Spearman correlation of input cell 's expression with candidate reference profile ) ( + ( , ) ) the cumulative probability of j's correlation within the distribution of selfcorrelations + ( , ), that is, of all reference cells of type with their 'own' candidate reference profile 1 ( + ( , ) ) the cumulative probability of j's correlation within the distribution of correlations + ( , ) of all reference cells under the other branch, again with reference profile
The profile score " ( )has a value between 1 and -1 and is, in a particular node, a measure for the likelihood that cell j is of type x. A value of 1 means that cell j is much more likely to be of type x (and therefore belong to its branch) rather than any of the types in the other branch and, conversely, -1
represents the lowest likelihood of this being so, and therefore cell j is much more likely to belong in the other branch. In each node, one set of genes is selected for each RP under that node. This gene set is used for all the correlations (of both input and reference cells) needed to calculate the profile scores. Note that due to the different gene subsets used in each step of the tree traversal, the most similar RP for a cell may change during the steps of the classification process. E.g., during the first few steps a cell that in reality is of type CD4 T-cell could initially and, incorrectly, appear more similar to a CD8 T-cell than to the expected CD4 T-cell type. This would however still lead to the correct branch choice, namely that of all Tcells. In later steps the similarity to the actual CD4 T-cell type would become strongest, guiding the cell to a correct final CD4 T-cell label.
Confidence score
Each input cell is assigned to the branch containing the candidate reference cell type for which it has the highest profile score. This assignment represents the choice between the left and right branch, but a key design goal of the algorithm is its ability to stop classification at an intermediate node. The choice for each cell j, between stopping classification or continuing to the next round, is based on its confidence score ( )defined as
with 67" ( ) the highest profile score for cell j in the branch about to be chosen and 1 ( ) the mean of the profile scores in the other branch, i.e. the branch not containing the reference profile having the highest profile score ( Figure 1C ). Expression [2] is always positive because branches leading to a negative score are by definition never chosen by the algorithm. The confidence score is a measure for the evidence to assign a cell to a branch, with 2 representing maximal evidence, and 0 representing no evidence. The confidence score has an easy explanation. If it is close to 0, the best candidate cell type in the branch about to be chosen is as good as the average of the cell types in the other branch. This implies that there is no basis to justify the choice between either branch, so none should be taken and classification of the cell should therefore stop in the current node. In contrast, a large score represents good support to continue the classification because there is a cell type in the candidate branch that has a much better profile score than the average profile score of the other branch. By default, cells are assigned to the branch if the confidence score is higher than 0.1, but different values can also be specified in the 
RESULTS
The CHETAH algorithm can be recapitulated as follows. Reference cell types are hierarchically clustered into a classification tree which functions as a taxonomic key for the cell type identification process. The cells to be classified are shunted from the root of this tree to its leaves, but only to the most specific tree node that is still supported by the available evidence, as quantified by a robust measure of confidence.
Cells for which this confidence runs out are typically of a type that is not present in the reference, and are said to be either unassigned or of an intermediate type. Note that there are several intermediate types,
each corresponding to one of the internal nodes of the classification tree.
CHETAH's accuracy is investigated by comparing its classifications with published cell type labels. The aim is to reproduce these using only the reference data. Since the accuracy might be lower if the scRNA-seq technology of the input data and the reference differs, cross-platform results are also examined. CHETAH is subsequently compared to other cell type identification methods and the effectiveness of the intermediate cell type assignments is also demonstrated in an analysis of previously published pancreas datasets.
Accuracy
The performance of CHETAH is first evaluated by applying it to melanoma 25 and head-neck 26 cancer datasets. The classifications of the these datasets is shown in Figures 2A,B Figure   S2 . Rows of panels: datasets classified (Melanoma: Tirosh et al. 25 
Cross-platform classification
The data from the Melanoma and Head-Neck studies were obtained using Smart-seq2 38 and were also classified using reference data originating from the same platform. To evaluate CHETAH's performance across platforms, an ovarian tumor dataset 19 produced on the inDrops platform 39 was analyzed with CHETAH using the Smart-Seq2-based reference. The results, presented in Figure 2C ,D and Table 1, show a performance similar to that obtained within one platform. This robustness is probably due to the use of rank-based similarities, implying that other combinations of scRNA-seq technologies will likely yield similar good results.
Comparison with existing methods
The important challenge of cell type identification has recently also started to be addressed through the development of other automated approaches. CHETAH was therefore next compared to the state-of-theart methods CaSTLe 40 , scmap 31 (both versions, i.e. scmap_cell and scmap_cluster) and SingleR 32 by running these programs with standard settings on the Ovarian, Melanoma and Head-Neck datasets ( Figure 3A) . To evaluate the performance also on non-tumor tissues, two pancreas datasets, Pancreas1 17 and Pancreas2 41 were included and mutually classified using the other as the reference. To avoid bias the same reference data was used for all classification methods. The ground truth for the classifications are the cell type labels from the original publications, but without the malignant cells from the tumor datasets. They are not part of the reference data and should therefore be considered as an unknown cell type and remain unassigned or intermediate.
To compare methods, two classes of input cells can be distinguished, namely (1) the cells that are of a type that is present in the reference and (2) cells for which no reference is available ( Figure 3B ).
For the first class it is meaningful to assess thecorrectness of the classification, because an optimal method should correctly identify all such cells. Those cell type inferences can therefore be correct or incorrect, corresponding to the true and false positives respectively ( Figure 3B ). In addition, the In the cancer datasets, CHETAH generally outperforms other methods ( Figure 3A ) in terms of combined true positives (correct assignments) and true negatives (cells correctly left unclassified). This is particularly important for studies of cancer since malignant cells are typically very patient specific and would almost always be misclassified by greedy methods. SingleR, having no classification cut-off, always classifies all cells to a final type, leading to a large number of erroneously assigned cells in cancer samples with many malignant cells (Figure 3 ). For example, both the cancer-associated fibroblasts (CAFs) and malignant cells are all classified as CAFs by SingleR. In datasets containing many unknown cells such as the malignant cells in the cancer samples, such approaches would therefore require very careful post hoc inspection of the classification on a per cell or per cluster basis, an approach that automated methods are meant to obviate. The selective nature of CHETAH makes the analysis much more efficient. As anticipated, forcing CHETAH to become greedy and classify all cells by applying a confidence score threshold of 0, yields a performance almost identical to SingleR's ( Figure 3) .
In contrast to the cancer datasets, the pancreas data are less complex, containing cell types with strong differential gene expression and few unknown cells. Note that a perfect classifier should leave none of the cells in the Pancreas2 dataset unidentified, because all its cell types are represented in the Pancreas1 reference. The converse is not true because for some of the cell types no distinction is made in Pancreas1. This is the reason that all the methods perform better on Pancreas2 ( Figure 3A ). In this comparison on non-cancer datasets, CHETAH's forte of rarely classifying cells without sufficient resemblance to the reference cell types is diminished. This results in a performance similar to that of the other methods (Figure 3 ). However, as is exemplified below, the inclusion of an intermediate assignment can have benefits for such datasets too.
Intermediate types
In data from tumor samples the classification to an intermediate type suggests, by exclusion, that a cell is aberrant and therefore potentially malignant. The position in the classification tree, of the node of an intermediate type may shed further light on the biology of these cells. For example, in the Melanoma and Head-Neck datasets, 54% and 74% respectively of the malignant cells, classify to the node directly above endothelial. This suggests that the expression pattern of these cells shares characteristics with endothelial and fibroblast types (see Figures S2A,B for the classification trees). Conversely, these cells display no affinity with the hematopoietic lineage, which is consistent with these tumors not being of hematopoietic origin. Classification to an intermediate type in combination with the position in the classification tree is therefore useful for analysis of cancer datasets.
Assignment to an intermediate cell type can also be useful in non-cancer datasets. This is demonstrated by two examples. In the Pancreas1 dataset, two kinds of stellate cells were originally identified, both of which are of mesenchymal origin 42 . PDGFRA and RGS5 were applied as marker genes for activated and quiescent stellate cells respectively. Pancreas2 only contains the more general label mesenchymal, and the corresponding cells only exhibit expression of PDGFRA but not RGS5 ( Figure S5 ), implying that these reference cells more closely resemble activated rather than quiescent stellate cells.
When CHETAH classifies the Pancreas1 dataset using the more limited Pancreas2 reference data, it correctly identifies the Pancreas1 activated stellate cells as mesenchymal while leaving the quiescent stellate cells unassigned, or assigning them to the node directly above the endothelial and mesenchymal types ( Figure S7B ), correctly determining that these cells are of a mesenchymal type not represented in the reference.
Acinar -duct cell gradient in pancreas data
Another useful consequence of allowing an intermediate type is exemplified in Figure 4 . Some cells in a cluster identified as acinar in the Pancreas2 publication are labeled ductal by CHETAH ( Figure 4A) , while conversely the cluster called ductal in the Pancreas1 study is partly classified as acinar ( Figure S7A ). The presence of these mixed acinar-ductal groups in both datasets suggests a shared underlying phenomenon. Acinar and ductal cells arise from the same progenitors and are closely related 43 . They are separated by only one node in CHETAH's classification tree ( Figures 4B and S7B) , which is the intermediate type to which CHETAH assigns the remaining cells of these clusters. When visualizing the profile score for duct cell in this intermediate node (arrows in Figures 4B and S7B) , a smooth gradient is clear in both clusters (Figures 4C and S7C ). . For the heatmap with all genes annotated see Figure S6 .
A heatmap of the expression of the genes most strongly (anti)correlating with this profile score shows the well-known cell type markers for these cell types ( Figures 4D and S7D) . These cell type-specific markers again exhibit a gradient of decreasing ductal and increasing acinar expression. Among the negatively correlating genes are acinar markers like CPA1, PRSS1 and CTRC 44, 45 and among the positively correlating genes are pancreas duct cell markers like KRT7 and KRT19 46 . A similar gradient in the expressions of genes having unusually large loadings in the first principal component of their ductal cell population has been reported previously 17 . This is a different manifestation of the fact that, for these cells, there is no dichotomy between acinar and ductal. Instead, the type of these cells is best described as lying on a continuum between acinar and ductal. The intermediate type assignment and profile score provide a direct and intuitive visualization highlighting such cases and the utility of the approach taken by CHETAH.
DISCUSSION
Classification of cell types in scRNA-seq data is an essential step that was by necessity initially performed manually 27, 25, 26, 19 . Owing to the subjective and time-consuming nature of manual approaches, automated approaches have recently been developed 31, 40, 32 . CHETAH has several features which work in its favour.
Importantly, it compares input cell data with real, rather than imputed reference cell profiles. Moreover, besides using correlations, the classification decision is also based on a confidence score determined by the degree to which an input cell matches the expression variance embodied by the cumulative distribution function of the correlations to the reference cells. This facilitates the highly selective nature of CHETAH, underlying the ability to classify cells as specifically as the input and reference data allows, but without greedy over-classification, as controlled through the confidence score threshold. One consequence is the assignment to intermediate or unassigned cell types for input cells not present in the reference data. The assignment to an intermediate or unassigned type is essential to prevent overclassification and acts as an automated flag to more closely inspect such cells. The importance of this is evident both from the tumor datasets for which the method was initially devised, but also for noncancer datasets as is also exemplified. In the tumor datasets analysed here practically all malignant cells were classified to intermediate types. Although genetic lesions such as copy number variations can be used to identify malignant cells 25 , this does represent an additional step. Moreover, such aberrations are not necessarily present (as in many pediatric tumors 43, 44 ) and/or may not be readily detectable. In the pancreas datasets, CHETAH uncovers a group of cells exhibiting a gradient of profiles between acinar and ductal, previously suggested to be centroacinar cells 10 . An alternative explanation is that these are acinar cells undergoing acinar-to-ductal transdifferentiation or metaplasia (ADM) 34 . This is commonly seen in acinar cells that, like those in both pancreas studies discussed here, are cultured for several days 35 or subjected to stresses or injury 36 . Subtle phenomena such as the acinar-ductal gradient are easily overlooked by greedy methods and especially by (manual) methods that assign the same cell type to all cells of one apparent cluster. Classification of cells from diverse tissues and diseases will become easier with the increasing availability of scRNA-seq datasets. Efforts like the Human Cell Atlas (HCA) 24 are aimed at generating scRNA-seq datasets for almost each (healthy) tissue and cell type.
CHETAH's accurate handling of unknown cell types should prove useful in discovering novel cell types in such data. Conversely, the annotated HCA data would be very suitable as a reference for CHETAH.
CHETAH is not limited to the use of scRNA-seq and can likely be used with other quantitative single cell data such as those obtained using DNA accessibility 48, 49 , chromatin state 50 , methylome 51 , epitope 52 or RNA velocity 53 sequencing methods, provided sufficiently rich reference data is available.
Although the full range of single cell genome-wide approaches can be expected to increase further in the near future, the need for methods such as CHETAH that improve the ease and precision of the analysis of the resulting data is evident.
SOFTWARE AVAILABILITY
CHETAH is available at github.com/jdekanter/CHETAH. All scripts that are needed to perform the analyses mentioned in this paper and to create the t-SNE plots using Seurat 13 are deposited at github.com/jdekanter/CHETAH_paper_figures.
Supplementary
Data are available at NAR online. Figure S2 . The classification trees used for the tumor datasets. Note that the trees are similar and reflect known biology. Small differences can arise due to a limited number of reference cells available (e.g. just 14 NK reference cells in the Melanoma classification tree). In the Melanoma and Head-Neck datasets, respectively 54% and 74% of the cells labeled as malignant cells classify to the node above cancer associated fibroblasts and endothelial. Figure S3 . When CHETAH classification differs from the one assigned in the Melanoma study (Figure 2A Figure S5 . t-SNE plots coloured by the normalized expression of the gene indicated. Rows of the panels: the data classified, as indicated; columns: gene whose expression is shown. In the Pancreas1 publication the RGS5 gene was used as a marker for quiescent stellate cells whereas PDGFRA was used as a marker for activated stellate cells. The Pancreas2 dataset only has expression of PDGFRA, not of RGS5. Figure S6 . The heatmap shown in main Figure 4D , but with all genes labeled. Heatmap showing the normalized expression of genes used by CHETAH to calculate this profile score. Only the genes that correlate, or anti-correlate more than 0.5 with this profile score in these populations are shown. Rows are genes, columns are cells. The columns are sorted by the duct cell profile score which is shown above the heatmap. For the heatmap with all genes annotated see Figure S6 . Note: both CHETAH and scmap have difficulty classifying the alpha cells of one of the donors (as identified in the original publication, here indicated by ' ') as they have an unusually low expression of the relevant markers.
